| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $23.05M | - | |
| Other | 52.8K | $8.66M | - | |
| Other | 46.8K | $7.68M | - | |
| Other | 39.6K | $6.51M | -36,937 | |
| Other | 36.8K | $6.05M | -11,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2018 | Grigoriadis Dimitri E. | Chief Research Officer | Sale+OE | 23,000 | $105.00 | $2,415,000.00 | -21.7% | |
| Jun 14, 2018 | Grigoriadis Dimitri E. | Chief Research Officer | Sale+OE | 86,963 | $99.48 | $8,650,738.28 | -25.9% | |
| Jun 13, 2018 | Lyons Gary A54 | Director | Sell | 15,000 | $99.24 | $1,488,549.00 | -5.4% | |
| Jun 11, 2018 | Sherwin Stephen A | Director | Sell | 10,000 | $98.44 | $984,420.00 | -17.4% | |
| Jun 1, 2018 | Benevich Eric62 | Chief Commercial Officer | Sell | 12,350 | $97.34 | $1,202,163.82 | -42.5% | |
| May 7, 2018 | Nevinny Corinne H | Director | Sell | 5,000 | $83.13 | $415,625.00 | -10.4% | |
| May 1, 2018 | Gorman Kevin Charles55 | Chief Executive Officer | Sale+OE | 126,832 | $80.75 | $10,241,734.73 | -26.8% | |
| Mar 5, 2018 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 75,873 | $90.00 | $6,828,570.00 | -21.8% | |
| Mar 5, 2018 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 1,979 | $88.47 | $175,089.65 | -11.0% | |
| Mar 5, 2018 | Gano Kyle54 | Chief Business Development Off | Sale+OE | 23,650 | $90.00 | $2,128,500.00 | -23.1% |